Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Plasma Proteomic Profiling of Young and Older Adults Identifies Candidate Biomarkers of Biological Aging at the Intersection of Age and Disease.

Aging cell·2026

Same author

Acute biological age as a determinant of adverse outcomes requiring hospitalization in Danish emergency department patients.

Communications medicine·2026

Same author

Evaluating the non-specific effects of BCG vaccination on the immune system and serological response to influenza vaccination in the elderly: A randomised controlled trial.

Vaccine·2026

Same author

Harnessing arginase 2-specific CD8+ T cells to target immunosuppressive cutaneous T-cell lymphoma.

The British journal of dermatology·2025

Same author

OMIP-115: High-Dimensional Phenotypic Characterization of Human Natural Killer Cells for Therapeutic Use.

Cytometry. Part A : the journal of the International Society for Analytical Cytology·2025

Same author

Role of NK Cells in Progression and Treatment of Multiple Myeloma.

Frontiers in bioscience (Landmark edition)·2025

Same journal

Endosymbiotic theory of aging revisited: Age-related leakage of mitochondrial dsDNA/RNA stimulates cytosolic nucleic acid sensors which remodel the immune network and promote the aging process.

Biogerontology·2026

Same journal

Emodin alleviates radiation-induced pulmonary fibrosis by targeting cellular senescence via the mtDNA-cGAS-STING axis.

Biogerontology·2026

Same journal

Natural modulators of enhancer of zeste homolog 2 (EZH2): potential epigenetic regulators of aging-associated pathways.

Biogerontology·2026

Same journal

MSC-derived extracellular vesicles accelerate wound healing in senescent fibroblast cultures.

Biogerontology·2026

Same journal

A multi-ingredient food supplement slows age-dependent decline of mobility and influences gene expression in C. elegans.

Biogerontology·2026

Same journal

Correction: Hormetic efficacy of rutin to promote longevity in Drosophila melanogaster.

Biogerontology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

Strategies for future histocompatible stem cell therapy.

Jan O Nehlin¹, Torben Barington

¹Center for Stem Cell Treatment, Department of Clinical Immunology, University of Southern Denmark, Denmark. jnehlin@health.sdu.dk.

|February 17, 2009

Summary

This summary is machine-generated.

Human pluripotent stem cells offer regenerative potential for tissue repair. Patient-specific stem cells can be generated for cell therapy, addressing age-related decline in regenerative capacity.

More Related Videos

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Published on: June 18, 2018

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

Related Experiment Videos

Last Updated: Jun 25, 2026

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Published on: June 18, 2018

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

Area of Science:

Regenerative Medicine
Stem Cell Biology

Background:

Adult stem cell regenerative capacity declines with age.
Human pluripotent stem cells (hPSCs) offer unlimited self-renewal for tissue replacement.
Patient-derived nuclei or somatic cells can be reprogrammed into hPSCs.

Purpose of the Study:

To review experimental cell therapy technologies using patient-histocompatible stem cells.
To discuss challenges for clinical translation of stem cell therapies.
To explore the use of hPSC derivatives for disease treatment.

Main Methods:

Overview of human somatic cell nuclear transfer (SCNT) and induced pluripotent stem cell (iPSC) technologies.
Discussion of stem cell differentiation protocols and culture optimization.
Review of evidence for stem cell pool aging and loss.

Main Results:

Patient-histocompatible hPSCs can be generated and differentiated into various cell types.
Potential to enrich specific cell lineages for therapeutic transplantation.
Evidence suggests a decline in stem cell function with aging.

Conclusions:

Patient-specific hPSCs hold promise for regenerative medicine and treating age-related diseases.
Further research is needed to optimize differentiation and address clinical trial hurdles.
Cell therapy using hPSC derivatives could revolutionize disease treatment and health improvement.